Related Experiment Video

Updated: Mar 13, 2026

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
09:29

Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies

Published on: September 30, 2016

14.5K

CDK5 functions as a tumor promoter in human colorectal cancer via modulating the ERK5-AP-1 axis

Kangmin Zhuang1, Juchang Zhang1, Man Xiong1

  • 1Guangdong Provincial Key Laboratory of Gastroenterology, Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.

Cell Death & Disease
|October 14, 2016
PubMed

Insights

Cyclin-dependent kinase 5 (CDK5) is upregulated in colorectal cancer (CRC), promoting tumor growth and metastasis. Targeting the CDK5-ERK5-AP-1 pathway may offer a new therapeutic strategy for CRC patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Abnormal cyclin-dependent kinase 5 (CDK5) expression is implicated in various cancers.
  • The specific role of CDK5 in colorectal cancer (CRC) pathogenesis remains largely uncharacterized.

Purpose of the Study:

  • To investigate the role and underlying mechanisms of CDK5 in colorectal cancer (CRC) development.
  • To explore the potential of CDK5 as a therapeutic target for CRC.

Main Methods:

  • Analysis of CDK5 expression in CRC tissues versus normal tissues.
  • Cellular function assays to assess CDK5's impact on CRC cell proliferation and metastasis.
  • Molecular techniques including whole-genome microarray, co-immunoprecipitation, kinase assays, western blotting, luciferase reporter assays, and electrophoretic mobility shift assay (EMSA).

Main Results:

  • CDK5 expression is significantly higher in CRC tissues and correlates with advanced AJCC stage, poor differentiation, larger tumor size, and worse prognosis.
  • CDK5 promotes CRC cell proliferation and metastasis.
  • CDK5 directly phosphorylates ERK5 at Thr732, modulating the ERK5-AP-1 signaling pathway.
  • The CDK5-ERK5-AP-1 axis is crucial for CRC carcinogenesis and progression, showing significant correlation in human samples.

Conclusions:

  • CDK5 plays a critical role in the development and progression of colorectal cancer.
  • The study elucidates the functional and mechanistic link between CDK5 and the oncogenic ERK5-AP-1 pathway in CRC.
  • CDK5 represents a potential therapeutic target for colorectal cancer.

More Related Videos

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer08:34

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer

Published on: April 13, 2015

10.8K
An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

14.5K

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.6K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
6.7K
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

3.0K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.3K